Raised to Date
$492,500*
ID:
DMVC-NUVO-2022
Exemption:
REG-D (506b)
Issue Type:
Convertible Note
Accredited Only:
Yes
Reviewed Financials:
No
Price per Unit:
$1.00
Minimum Investment:
$2,000
Requested Investment:
$5,000
Investment Increments:
$500
Minimum Goal:
$500,000
Maximum Goal:
$550,000
Raise Start Date:
October 14th, 2022
Raise End Date:
November 15th, 2022
* Previously Raised:
$400,000
Highlights:
Nuvothera is a proven and growing early-stage consumer healthcare company focusing on dermatology conditions. It sells unique, highly effective OTC products supplemented with natural botanical ingredients that produce prescription-like results. Having a track record of doubling annual sales from its internet-based business, Nuvothera will launch into the large retail drugstore channel after having recently secured distribution with CVS and Walgreens. Nuvothera launched its OTC psoriasis treatment in the retail drugstore channel in early 2022 with plans to launch a pipeline of high-potential OTC dermatology products to sustain rapid long-term growth.
Log in above for more details and to invest.